Purpose: A prospective, random ized phase III, clinical trial was perform ed to assess treatm ent related acute toxicity, early response and survival difference, between a m onthly 5-FU+cisplatin, and a weekly cisplatin group alone, for concurrent chemoradiotherapy in the locally advanced uterine cervical carcinoma patients. 
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